Nutrien Ltd. (NYSE:NTR) Shares Acquired by Park Avenue Securities LLC

Park Avenue Securities LLC lifted its holdings in Nutrien Ltd. (NYSE:NTRGet Rating) by 11.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,707 shares of the company’s stock after purchasing an additional 375 shares during the period. Park Avenue Securities LLC’s holdings in Nutrien were worth $311,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of NTR. Zions Bancorporation N.A. raised its stake in shares of Nutrien by 55.2% during the 1st quarter. Zions Bancorporation N.A. now owns 301 shares of the company’s stock worth $31,000 after buying an additional 107 shares during the period. Crossmark Global Holdings Inc. grew its holdings in Nutrien by 0.3% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 38,626 shares of the company’s stock valued at $3,078,000 after buying an additional 124 shares in the last quarter. Cadence Wealth Management LLC increased its holdings in shares of Nutrien by 3.7% during the 2nd quarter. Cadence Wealth Management LLC now owns 3,489 shares of the company’s stock worth $278,000 after buying an additional 126 shares during the last quarter. Centaurus Financial Inc. raised its position in Nutrien by 0.9% in the second quarter. Centaurus Financial Inc. now owns 14,753 shares of the company’s stock valued at $1,176,000 after purchasing an additional 127 shares during the period. Finally, Van Strum & Towne Inc. lifted its position in Nutrien by 1.0% in the second quarter. Van Strum & Towne Inc. now owns 13,981 shares of the company’s stock valued at $1,114,000 after buying an additional 135 shares during the last quarter. Institutional investors and hedge funds own 64.52% of the company’s stock.

Nutrien Stock Performance

Shares of NTR stock opened at $78.82 on Monday. The company has a quick ratio of 0.70, a current ratio of 1.15 and a debt-to-equity ratio of 0.27. The stock’s 50-day moving average price is $76.43 and its 200 day moving average price is $81.90. Nutrien Ltd. has a 52-week low of $67.41 and a 52-week high of $117.25. The stock has a market capitalization of $40.03 billion, a PE ratio of 5.61, a price-to-earnings-growth ratio of 0.85 and a beta of 0.86.

Nutrien (NYSE:NTRGet Rating) last posted its quarterly earnings results on Wednesday, November 2nd. The company reported $2.51 earnings per share for the quarter, missing analysts’ consensus estimates of $3.92 by ($1.41). The business had revenue of $8.19 billion during the quarter, compared to analysts’ expectations of $9.02 billion. Nutrien had a net margin of 20.60% and a return on equity of 29.68%. As a group, equities research analysts forecast that Nutrien Ltd. will post 13.52 EPS for the current year.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 13th. Investors of record on Friday, December 30th were issued a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.44%. The ex-dividend date of this dividend was Thursday, December 29th. Nutrien’s dividend payout ratio is currently 13.67%.

Analyst Ratings Changes

Several analysts have recently issued reports on NTR shares. Citigroup reduced their price target on shares of Nutrien from $87.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday. Raymond James reduced their target price on shares of Nutrien from $95.00 to $90.00 and set an “outperform” rating on the stock in a report on Friday, January 13th. BMO Capital Markets lowered their price target on shares of Nutrien from $115.00 to $110.00 and set an “outperform” rating for the company in a report on Friday, November 4th. Royal Bank of Canada decreased their price objective on shares of Nutrien from $135.00 to $120.00 and set an “outperform” rating for the company in a research report on Monday, November 7th. Finally, Barclays lowered their price objective on Nutrien from $105.00 to $95.00 and set an “overweight” rating for the company in a research report on Thursday, November 17th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $98.06.

Nutrien Profile

(Get Rating)

Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.

Recommended Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRGet Rating).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.